Camille Schiffler

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 304 citations

Oncology, Adult Patients, Metronomic Therapy +8

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

Florence Duffaud, Antoîne Italiano, Emannuelle Bompas et al. · European Journal of Cancer · 2021 · 46 citations · Full text

Surgical Oncology, Advanced Chondrosarcoma, Medicine +6

Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study

Florence Duffaud, Jean‐Yves Blay, Axel Le Cesne et al. · British Journal of Cancer · 2023 · 28 citations · Full text

Surgical Oncology, Advanced Ewing Sarcoma, Medicine +6

A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

Jean‐Yves Blay, Camille Schiffler, Olivier Bouché et al. · Annals of Oncology · 2024 · 27 citations · Full text

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

Pauline Rochefort, Sylvie Chabaud, Jean‐Yves Pierga et al. · British Journal of Cancer · 2017 · 26 citations · Full text